These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6519158)

  • 21. A review of the clinical pharmacokinetics of amiodarone.
    Paton DM; Webster DR; Neutze JM
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):41-9. PubMed ID: 6371407
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
    Debbas NM; Du Cailar C; Sassine A; Derancourt J; Demaille JG; Puech P
    Eur J Clin Invest; 1983 Apr; 13(2):123-7. PubMed ID: 6409635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
    Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
    Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP; Prystowsky EN; Heger JJ
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
    Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
    J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy.
    Canada AT; Lesko LJ; Haffajee CI; Johnson B; Asdourian GK
    Drug Intell Clin Pharm; 1983 Feb; 17(2):100-4. PubMed ID: 6337802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients.
    Iervasi G; Clerico A; Manfredi C; Sabatino L; Biagini A; Chopra IJ
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):699-705. PubMed ID: 9497877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine kinetic studies during amiodarone treatment.
    Rao RH; McCready VR; Spathis GS
    J Clin Endocrinol Metab; 1986 Mar; 62(3):563-8. PubMed ID: 3944239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
    Stäubli M; Bircher J; Galeazzi RL; Remund H; Studer H
    Eur J Clin Pharmacol; 1983; 24(4):485-94. PubMed ID: 6861863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue extraction of amiodarone and N-desethylamiodarone in man after a single oral dose.
    Berdeaux A; Roche A; Labaille T; Giroux B; Edouard A; Giudicelli JF
    Br J Clin Pharmacol; 1984 Nov; 18(5):759-63. PubMed ID: 6508984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometric identification of amiodarone N-monodesethyl metabolite and application of an HPLC method to a pharmacokinetic study.
    Marchiset D; Aubert C; Sumirtapura YC; Egre A; Cano JP
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):123-8. PubMed ID: 6745303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of amiodarone in rats after single and multiple intra-peritoneal doses.
    Najjar TA
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):199-203. PubMed ID: 11420890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients.
    Flanagan RJ; Storey GC; Holt DW; Farmer PB
    J Pharm Pharmacol; 1982 Oct; 34(10):638-43. PubMed ID: 6128385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.
    Anastasiou-Nana M; Koutras DA; Levis G; Souvatzoglou A; Boukis MA; Moulopoulos SD
    J Endocrinol Invest; 1984 Aug; 7(4):405-7. PubMed ID: 6501809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.